-
Baicalin Workflows for Visual Plasticity Research
2026-08-20
Baicalin offers a defined small-molecule workflow for testing adult cortical plasticity, with a reported 10 mg/kg benchmark in an amblyopia model and mechanistic readouts spanning GABAergic inhibition and perineuronal nets. Its formulation and pathway profile also support carefully separated exploratory studies in oxidative stress and cancer research.
-
Annexin V-Cy5/DAPI Apoptosis Kit Guide
2026-08-20
Learn how SKU K2255 supports rapid, two-parameter apoptosis and necrosis assessment when metabolic viability results are difficult to interpret. This scenario-driven guide covers assay principles, controls, protocol optimization, flow-cytometry interpretation, and practical vendor selection.
-
Irinotecan CPT-11: Reproducible Cell Assays
2026-08-19
Learn how Irinotecan (CPT-11, SKU A5133) can improve the interpretation and reproducibility of cell viability, proliferation, and cytotoxicity assays. This scenario-based guide covers prodrug activation, solubility, dose design, translational limits, and practical supplier selection.
-
Baicalin: From Cortical Plasticity to Assay Design
2026-08-19
Baicalin is emerging as a research tool for studying adult cortical plasticity, with evidence linking reduced GABAergic inhibition to visual recovery in mice. This article translates that finding into practical assay, formulation, and cross-domain interpretation guidance.
-
Topotecan and Dna2: Mapping Replication Stress
2026-08-18
Topotecan, also known as SKF104864, can function as more than a cytotoxic agent: it is a controllable probe of replication-fork stress and DNA-repair capacity. This article connects Topo I trapping with Dna2-dependent phenotypes to improve assay design in cancer research, glioma models, and pediatric tumor studies.
-
Drug-Sensitized Yeast for mTOR Inhibitor Discovery
2026-08-18
Breen and colleagues developed a drug-sensitized Saccharomyces cerevisiae platform that detects TOR pathway inhibitors at substantially lower concentrations than a wild-type yeast background. The system identified concentration-dependent activity for established inhibitors and aminophylline, while finding no evidence of TOR inhibition for several other compounds, including nebivolol.
-
Topotecan in First-Line Small Cell Lung Cancer
2026-08-17
This review evaluates Topotecan as an investigational first-line option for small cell lung cancer, emphasizing its distinct topoisomerase I mechanism, combination potential, and manageable noncumulative toxicity. Phase II signals were promising, but the authors appropriately identify the need for confirmatory trials before routine replacement of platinum–etoposide therapy.
-
P2RX1, Calcium Signaling, and Apoptosis in Ph+ ALL
2026-08-17
A 2025 study identifies P2RX1 as a regulator of tyrosine kinase inhibitor sensitivity in Philadelphia chromosome-positive acute lymphoblastic leukemia, linking excessive purinergic signaling to calcium/CaMKII activation, PI3K/Akt suppression, mitochondrial dysfunction, and intrinsic apoptosis. Its findings provide a mechanistic framework for interpreting drug-induced cell death while highlighting the need for orthogonal apoptosis and mitochondrial assays.
-
Camptothecin Workflows for DNA Damage Research
2026-08-16
Camptothecin is a mechanistically defined topoisomerase I inhibitor for connecting DNA lesions with cell fate, autophagy, and adaptive evolution. This workflow shows how to optimize exposure, separate acute damage from long-term selection, and translate prion-driven mutagenesis findings into practical cancer-biology assays.
-
CUDC-907: Practical In Vitro Protocol Guide
2026-08-15
CUDC-907 is a dual PI3K and HDAC inhibitor for controlled cell-based studies of PI3K/AKT signaling, HDAC activity, cell-cycle behavior, and apoptosis. This guide uses product-dossier values as starting points and is intended for research workflows only, not for diagnosis, treatment, or clinical use.
-
Notch Receptor Interactomes and ATXN2 Recycling
2026-08-14
Bian et al. used TurboID proximity labeling, affinity purification, and mass spectrometry to map human NOTCH receptor interaction networks according to cellular location. The study identifies ER-Golgi intermediate compartment storage and ATXN2-dependent rapid recycling as mechanisms that prepare NOTCH receptors for signaling, with implications for Notch-driven leukemia biology.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-08-14
HyperFluor 488 Goat Anti-Rabbit IgG is a fluorescent antibody conjugate for detecting rabbit primary antibodies in immunofluorescence, microscopy, and flow cytometry workflows. It is intended for fixed-sample or otherwise validated fluorescence assays, not as an automatically interchangeable reagent for non-rabbit primaries, live-cell applications, or non-fluorescent detection formats.
-
Toxoplasma GRA15, CCL5, and Brain Sequestration
2026-08-13
Afanaseva and colleagues identify a mechanism by which Toxoplasma gondii exploits GRA15-dependent CCL5/CCR5 signaling to retain infected dendritic cells in brain microvessels. The work connects parasite effector biology with endothelial chemokine responses, leukocyte trafficking, and early central nervous system colonization.
-
HOXC8, Caspase-1, and Lung Tumorigenesis
2026-08-13
A 2025 Cell Death and Disease study shows that HOXC8 supports non-small cell lung cancer cell survival by repressing CASP1 transcription through HDAC1/2 recruitment, thereby preventing ASC-independent pyroptosis. The findings connect a transcriptional regulatory circuit to GSDMD-mediated cell death and suggest that HOXC8 depletion may be a strategy for limiting NSCLC tumorigenesis.
-
Palbociclib: A Cell-Cycle Lens on DNA Repair
2026-08-12
Palbociclib (PD0332991) is more than a CDK4/6 arrest tool: it can help researchers define how cell-cycle state shapes DNA-damage phenotypes. This article connects Palbociclib assays with ERCC1, p53, apoptosis, and cisplatin-response biology while emphasizing experimental limits.